Characterization and manipulation of the human adenovirus 4 genome

Journal of General Virology

Volumn 85, Issue 11, 2004, Pages 3361-3366

  Jacobs, Susan C ^a   Davison, Andrew J ^b   Carr, Sharon ^c   Bennett, Alice M ^c   Phillpotts, Robert ^c   Wilkinson, Gavin W G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b INSTITUTE OF VIROLOGY   (United Kingdom)

^c DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENETIC ANALYSIS; GENETIC MANIPULATION; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 4; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEROTYPE; SIMIAN VIRUS; STRAIN DIFFERENCE; VIRUS GENE; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN;

ADENOVIRUSES, HUMAN; CELL LINE, TUMOR; DNA, VIRAL; GENOME, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; VIRAL VACCINES; VIRUS REPLICATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS B; HUMAN ADENOVIRUS E; HUMAN ADENOVIRUS TYPE 4; PAN (APE);

EID: 7444237148     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80386-0     Document Type: Article

References (36)

1. Barraza, E. M., Ludwig, S. L., Gaydos, J. C. & Brundage, J. F. (1999). Reemergence of adenovirus type 4 acute respiratory disease in military trainees: report of an outbreak during a lapse in vaccination. J Infect Dis 179, 1531-1533.
2. Benkö, M., Harrach, B. & Russell, W. C. (2000). Family Adenoviridae. In Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses, pp. 227-238. Edited by M. H. V. van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle & R. B. Wickner. San Diego: Academic Press.
3. Burgert, H. G., Ruzsics, Z., Obermeier, S., Hilgendorf, A., Windheim, M. & Elsing, A. (2002). Subversion of host defense mechanisms by adenoviruses. Curr Top Microbiol Immunol 269, 273-318.
4. Chanock, R. M., Ludwig, W., Heubner, R. J., Cate, T. R. & Chu, L. W. (1966). Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers. JAMA 195, 445-452.
5. Chengalvala, M., Lubeck, M. D., Davis, A. R., Mizutani, S., Molnar-Kimber, K., Morin, J. & Hung, P. P. (1991). Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs. Vaccine 9, 485-490.
6. Chengalvala, M. V., Bhat, B. M., Bhat, R., Lubeck, M. D., Mizutani, S., Davis, A. R. & Hung, P. P. (1994). Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs. J Gen Virol 75, 125-131.
7. Chengalvala, M. V., Bhat, B. M., Bhat, R. A., Dheer, S. K., Lubeck, M. D., Purcell, R. H. & Murthy, K. K. (1997). Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees. Vaccine 15, 335-339.
8. Crawford-Miksza, L. K. & Schnurr, D. P. (1996). Adenovirus serotype evolution is driven by illegitimate recombination in the hypervariable regions of the hexon protein. Virology 224, 357-367.
9. Crawford-Miksza, L. K., Nang, R. N. & Schnurr, D. P. (1999). Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease. J Clin Microbiol 37, 1107-1112.
10. Davison, A. J., Akter, P., Cunningham, C. & 7 other authors (2003a). Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes. J Gen Virol 84, 657-663.
11. Davison, A. J., Benkö, M. & Harrach, B. (2003b). Genetic content and evolution of adenoviruses. J Gen Virol 84 2895-2908.
12. Farina, S. F., Gao, G., Xiang, Z. Q., Rux, J. J., Burnett, R. M., Alvira, M. R., Marsh, J., Ertl, H. C. J. & Wilson, J. M. (2001). Replication-defective vector based on a chimpanzee adenovirus. J Virol 75, 11603-11613.
13. Gruber, W. C., Russell, D. J. & Tibbetts, C. (1993). Fiber gene and genomic origin of human adenovirus type 4. Virology 196, 603-611.
14. Hay, R. T. (1985). Origin of adenovirus DNA replication. Role of the nuclear factor I binding site in vivo. J Mol Biol 186, 129-136.
15. Hilleman, M. R. & Werner, J. H. (1954). Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med 85, 183-188.
16. Jacobs, S. C., Stephenson, J. R. & Wilkinson, G. W. G. (1992). High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J Virol 66, 2086-2095.
17. Kidd, A. H., Garwicz, D. & Öberg, M. (1995). Human and simian adenoviruses: phylogenetic inferences from analysis of VA RNA genes. Virology 207, 32-45.
18. Kitchingman, G. R. (1985). Sequence of the DNA-binding protein of a human subgroup E adenovirus (type 4): comparisons with subgroup A (type 12), subgroup B (type 7), and subgroup C (type 5). Virology 146, 90-101.
19. Li, Q.-G. & Wadell, G. (1988). The degree of genetic variability among adenovirus type 4 strains isolated from man and chimpanzee. Arch Virol 101, 65-77.
20. Li, Y. & Wold, W. S. M. (2000). Identification and characterization of a 30K protein (Ad4E3-30K) encoded by the E3 region of human adenovirus type 4. Virology 273, 127-138.
21. Lubeck, M. D., Davis, A. R., Chengalvala, M. & 8 other authors (1989). Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc Natl Acad Sci U S A 86, 6763-6767.
22. Lubeck, M. D., Natuk, R. J., Chengalvala, M. & 12 other authors (1994). Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res Hum Retrovir 10, 1443-1449.
23. Mason, B. B., Davis, A. R., Bhat, B. M. & 9 other authors (1990). Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron. Virology 177, 452-461.
24. McNeill, K. M., Hendrix, R. M., Lindner, J. L., Benton, F. R., Monteith, S. C., Tuchscherer, M. A., Gray, G. C. & Gaydos, J. C. (1999). Large, persistent epidemic of adenovirus type 4-associated acute respiratory disease in U.S. army trainees. Emerg Infect Dis 5, 798-801.
25. Patterson, L. J., Prince, G. A., Richardson, E., Alvord, W. G., Kalyan, N. & Robert-Guroff, M. (2002). Insertion of HIV-1 genes into Ad4ΔE3 vector abrogates increased pathogenesis in cotton rats due to E3 deletion. Virology 292, 107-113.
26. Pring-Åkerblom, P. & Adrian, T. (1995). Sequence characterization of the adenovirus 31 fibre and comparison with serotypes of subgenera A to F. Res Virol 146, 343-354.
27. Pring-Åkerblom, P., Trijssenaar, F. E. J. & Adrian, T. (1995). Sequence characterization and comparison of human adenovirus subgenus B and E hexons. Virology 212, 232-236.
28. Rubin, B. A. & Rorke, L. B. (1994). Adenovirus; vaccines. In Vaccines, 2nd edn, pp. 475-502. Edited by S. A. Plotkin & E. A. Mortimer. Philadelphia, PA: W. B. Saunders.
29. Scarpini, C., Arthur, J., Efstathiou, S., McGrath, Y. & Wilkinson, G. (1999). Herpes simplex virus and adenovirus vectors. In DNA Viruses: A Practical Approach, pp. 267-306. Edited by A. J. Cann. Oxford: Oxford University Press.
30. Tacket, C. O., Losonsky, G., Lubeck, M. D., Davis, A. R., Mizutani, S., Horwith, G., Hung, P., Edelman, R. & Levine, M. M. (1992). Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine. Vaccine 10, 673-676.
31. Tarassishin, L., Szawlowski, P., McLay, J., Kidd, A. H. & Russell, W. C. (1999). Adenovirus core protein VII displays a linear epitope conserved in a range of human adenoviruses. J Gen Virol 80, 47-50.
32. Taylor, P. (1986). A computer program for translating DNA sequences into protein. Nucleic Acids Res 14, 437-441.
33. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680.
34. Tokunaga, O., Shinagawa, M. & Padmanabhan, R. (1982). Physical mapping of the genome and sequence analysis at the inverted terminal repetition of adenovirus type 4 DNA. Gene 18, 329-334.
35. Tokunaga, O., Yaegashi, T., Lowe, J., Dobbs, L. & Padmanabhan, R. (1986). Sequence analysis in the E1 region of adenovirus type 4 DNA. Virology 155, 418-433.
36. Wilkinson, G. W. G. & Akrigg, A. (1992). Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 20, 2233-2239.